BSX Boston Scientific
- Official Name: BOSTON SCIENTIFIC CORPORATION
- Headquarters: 300 Boston Scientific Way, MARLBOROUGH, MA, 01752-1234 US
- CEO: Michael F. Mahoney
- Website: bostonscientific.com
- Key Investor: BLACKROCK, INC | 9.58%
- Dedicated Investor: BOLLARD GROUP LLC | 54.28%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-16 | 1 | Won by 0.219 | 0.169 - (0.050) | ||
| 2025-07-23 | 2 | Lost by 0.660 | 3.983 - 4.643 | ||
| 2025-07-29 | 2R | Lost by 0.105 | 1.003 - 1.108 | ||
| 2025-07-30 | 3 | Lost by 1.300 | (0.105) - 1.195 | ||
| 2025-08-06 | 4 | Lost by 5.150 | (4.032) - 1.118 | ||
| 2025-08-07 | 1R | Won by 0.265 | 0.078 - (0.187) | ||
| 2025-08-13 | 5 | Lost by 0.628 | (0.513) - 0.115 | ||
| 2025-08-20 | 6 | Won by 1.320 | 3.214 - 1.894 | ||
| 2025-08-21 | 2R | Lost by 2.287 | (1.006) - 1.281 | ||
| 2025-08-27 | 7 | Lost by 2.799 | (0.168) - 2.631 | ||
| 2025-09-03 | 8 | Won by 1.575 TOTW | 1.713 - 0.138 | ||
| 2025-09-10 | 9 | Lost by 2.594 | (2.114) - 0.480 | ||
| 2025-09-17 | 10 | Lost by 5.920 | (5.060) - 0.860 | ||
| 2025-09-17 | 1R | Lost by 2.180 | (0.437) - 1.743 | ||
| 2025-09-24 | 11 | Won by 1.291 | (0.387) - (1.678) | ||
| 2025-10-01 | 12 | Won by 3.447 | (1.976) - (5.423) | ||
| 2025-10-08 | 13 | Won by 4.077 | 0.862 - (3.215) | ||
| 2025-10-15 | 14 | Won by 2.050 | 0.924 - (1.126) | ||
| 2025-10-22 | 15 | Won by 6.882 | 6.754 - (0.128) |
Latest News
Boston Scientific: A Better Valuation, But The Turnaround Needs Proof

Is Medtronic Stock A Buy Now That Sales Growth Has Picked Up?
Investors considering Medtronic (MDT) stock face an immediate concern: the shares returned 1.9% over the past year, trailing the 17.3% gain for the S&...

Boston Scientific (BSX) Rises Higher Than Market: Key Facts
Boston Scientific (BSX) closed at $44.14 in the latest trading session, marking a +2.65% move from the prior day.

Is Boston Scientific Stock Riskier Than It Was A Year Ago?
Investors in Boston Scientific (BSX) hold stakes in a medical device maker that grew revenue 13.5% over the twelve months to June 2026. Yet the shares...

Boston Scientific (BSX) Recalls 262,686 Catheters Over Life Threatening Tip Failure Risk
Boston Scientific (NYSE: BSX) has begun a voluntary worldwide recall of its Imager II Angiographic Catheters due to catheter tip issues. The recall fo...

What Could BSX Stock Be Worth In Three Years?
Boston Scientific (BSX) stock currently trades at 17.2 times earnings. This compares to an average multiple of 55.9 over the last twelve quarter-ends,...

Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed...
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $51.

Earnings Preview: What to Expect From Boston Scientific’s Report
Boston Scientific will unveil its fiscal third-quarter results by the end of this month, and analysts forecast a single-digit uptick in its bottom lin...

Global Bioelectronic Medicine Device Market 2026 | Capitalize on 17% CAGR Through 2030 as Medtronic, Abbott, Boston Scientific and LivaNova Advance Closed-Loop Neurostimulation
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioelectronic Medicine Device Market Global Report 2026" has been added to ResearchAndMarkets.com...